Organic nanocarriers for cancer drug delivery

Current Opinion in Pharmacology

Volumn 12, Issue 4, 2012, Pages 414-419

  López Dávila, Víctor ^a   Seifalian, Alexander M ^a   Loizidou, Marilena ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CISPLATIN; CPX 1; CYTARABINE; DAUNORUBICIN; DENILEUKIN DIFTITOX; DOXORUBICIN; FLOXURIDINE; GEMCITABINE; IBRITUMOMAB TIUXETAN; IRINOTECAN; LIPOSOME; MITOMYCIN C; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NAVELBINE; NC 6004; PACLITAXEL; POLYGLACTIN; POLYLACTIDE; PREDNISOLONE; PROPOFOL; SMALL INTERFERING RNA; TAXANE DERIVATIVE; THERMODOX; TOSITUMOMAB I 131; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ANOREXIA; BLOOD TOXICITY; BREAST CANCER; CANCER INHIBITION; COLORECTAL CANCER; CUTANEOUS T CELL LYMPHOMA; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; FATIGUE; FOLLICULAR LYMPHOMA; GLIOBLASTOMA; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; KAPOSI SARCOMA; LIVER CANCER; LUNG CANCER; LYMPHOMATUS MENINGITIS; MALIGNANT NEOPLASTIC DISEASE; MICELLE; NANOENCAPSULATION; NAUSEA; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; VOMITING;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; HUMANS; MICELLES; NANOPARTICLES; NEOPLASMS;

EID: 84864971732     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.02.011     Document Type: Review

References (31)

1. T. Lammers, K. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J Control Release 161 2012 175 187 10.1016/j.jconrel.2011.09.063 epub
2. M. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 30 2009 592 599
3. D.R. Khan, E.M. Rezler, J. Lauer-Fields, and G.B. Fields Effects of drug hydrophobicity on liposomal stability Chem Biol Drug Des 71 2008 3 7
4. K. Moribe, E. Tanaka, K. Maruyama, and M. Iwatsuru Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives Pharm Res 15 1998 1737 1742
5. H.K. Kim, and T.G. Park Surface stabilization of diblock PEG-PLGA micelles by polymerization of N-vinyl-2-pyrrolidone Macromol Rapid Commun 23 2002 26 31
6. V.P. Torchilin, A.N. Lukyanov, Z. Gao, and B. Papahadjopoulos-Sternberg Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs Proc Natl Acad Sci USA 100 2003 6039 6044
7. H. Koide, T. Asai, K. Hatanaka, T. Urakami, T. Ishii, E. Kenjo, M. Nishihara, M. Yokoyama, T. Ishida, H. Kiwada, and N. Oku Particle size-dependent triggering of accelerated blood clearance phenomenon Int J Pharm 362 2008 197 200
8. X. Qu, V.V. Khutoryanskiy, A. Stewart, S. Rahman, B. Papahadjopoulos- Sternberg, C. Dufes, D. McCarthy, C.G. Wilson, R. Lyons, and K.C. Carter Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude Biomacromolecules 7 2006 3452 3459
9. E. Roda, T. Coccini, D. Acerbi, S. Barni, R. Vaccarone, and L. Manzo Comparative pulmonary toxicity assessment of pristine and functionalized multi-walled carbon nanotubes intratracheally instilled in rats: morphohistochemical evaluations Histol Histopathol 26 2011 357 367
10. H. Maeda, J. Fang, T. Inutsuka, and Y. Kitamoto Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications Int Immunopharmacol 3 2003 319 328
11. T. Lammers, P. Peschke, R. Kühnlein, V. Subr, K. Ulbrich, J. Debus, P. Huber, W. Hennink, and G. Storm Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems J Control Release 117 2007 333 341
12. E.S. Lee, K. Na, and Y.H. Bae Polymeric micelle for tumor pH and folate-mediated targeting J Control Release 91 2003 103 113
13. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
14. ®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Ann Oncol 15 2004 440 449
15. A.M. Keller, R.G. Mennel, V.A. Georgoulias, J. Nabholtz, A. Erazo, A. Lluch, L. Charles, C.L. Vogel, M. Kaufmann, and G. von Minckwitz Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer J Clin Oncol 22 2004 3893 3901
16. A. Gabizon Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy Cancer Invest 19 2001 424 436
17. K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, S.B. Kim, S.Y. Rha, M.Y. Lee, and J. Ro Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Br Cancer Res Treat 108 2008 241 250
18. R. Plummer, R.H. Wilson, H. Calvert, A.V. Boddy, M. Griffin, J. Sludden, M.J. Tilby, M. Eatock, D.G. Pearson, and C.J. Ottley A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours Br J Cancer 104 2011 593 598
19. A. Tan, H. De La Peña, and A.M. Seifalian The application of exosomes as a nanoscale cancer vaccine Int J Nanomed 5 2010 889 900
20. G. Batist, K.A. Gelmon, K.N. Chi, W.H. Miller Jr., S.K. Chia, L.D. Mayer, C.E. Swenson, A.S. Janoff, and A.C. Louie Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors Clin Cancer Res 15 2009 692 700
21. T. Lammers, V. Subr, K. Ulbrich, P. Peschke, P.E. Huber, W.E. Hennink, and G. Storm Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 30 2009 3466 3475
22. S.H. Kang, H.J. Cho, G. Shim, S. Lee, S.H. Kim, H.G. Choi, C.W. Kim, and Y.K. Oh Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy Pharm Res 28 2011 3069 3078
23. C.N. Landen Jr., A. Chavez-Reyes, C. Bucana, R. Schmandt, M.T. Deavers, G. Lopez-Berestein, and A.K. Sood Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery Cancer Res 65 2005 6910 6918
24. L. Davies Cde, L.M. Lundstrom, J. Frengen, L. Eikenes, S.O.S Bruland, O. Kaalhus, M.H. Hjelstuen, and C. Brekken Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts Cancer Res 64 2004 547 553
25. A.L. Seynhaeve, S. Hoving, D. Schipper, C.E. Vermeulen, G. de Wiel-Ambagtsheer, S.T. van Tiel, A.M. Eggermont, and T.L. Ten Hagen Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response Cancer Res 67 2007 9455 9462
26. X. Li, L. Ding, Y. Xu, Y. Wang, and Q. Ping Targeted delivery of doxorubicin using stealth liposomes modified with transferrin Int J Pharm 373 2009 116 123
27. H. Lee, K. Lee, and T.G. Park Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity Bioconjug Chem 19 2008 1319 1322
28. D.R. Khan The use of nanocarriers for drug delivery in cancer therapy J Cancer Sci Ther 2 2010 58 62
29. Y. Matsumura, M. Gotoh, K. Muro, Y. Yamada, K. Shirao, Y. Shimada, M. Okuwa, S. Matsumoto, Y. Miyata, and H. Ohkura Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer Ann Oncol 15 2004 517 525
30. N. Nasongkla, E. Bey, J. Ren, H. Ai, C. Khemtong, J.S. Guthi, S.F. Chin, A.D. Sherry, D.A. Boothman, and J. Gao Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems Nano Lett 6 2006 2427 2430
31. K.C. Weng, C.O. Noble, B. Papahadjopoulos-Sternberg, F.F. Chen, D.C. Drummond, D.B. Kirpotin, D. Wang, Y.K. Hom, B. Hann, and J.W. Park Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo Nanoletters 8 2008 2851 2857